Verve Therapeutics

OverviewSuggest Edit

Verve is a biotechnology company focused on discovering and developing therapies for coronary artery disease. It utilizes CRISPR (clustered regularly interspaced short palindromic repeats) and gene editing techniques to treat coronary artery and cardiovascular disease.

TypePrivate
Founded2018
HQCambridge, US
Websitevervetx.com

Latest Updates

Employees (est.) (Mar 2020)29(+16%)

Key People/Management at Verve Therapeutics

Kiran Musunuru

Kiran Musunuru

Co-Founder, Chief Scientific Advisor
David Neafus

David Neafus

Interim Chief Financial Officer
Keith Joung

Keith Joung

Co-Founder
Andrew Ashe

Andrew Ashe

President and Chief Operating Officer
Kallanthottathil Rajeev

Kallanthottathil Rajeev

Vice President, CMC
Anthony Philippakis

Anthony Philippakis

Co-Founder, Board Member
Show more

Verve Therapeutics Office Locations

Verve Therapeutics has an office in Cambridge
Cambridge, US (HQ)
215 First St #440
Show all (1)

Verve Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2018

Verve Therapeutics total Funding

$58.5 m

Verve Therapeutics latest funding size

$58.50 m

Time since last funding

a year ago

Verve Therapeutics investors

Verve Therapeutics's latest funding round in May 2019 was reported to be $58.5 m. In total, Verve Therapeutics has raised $58.5 m
Show all financial metrics

Verve Therapeutics Online and Social Media Presence

Embed Graph

Verve Therapeutics News and Updates

VC-backed Verve Therapeutics hires chief scientific officer

Cambridge, Massachusetts-based Verve Therapeutics, a next-generation cardiovascular company, has named Dr. Andrew Bellinger as chief scientific officer. Dr. Bellinger is a general cardiologist at Brigham and Women’s Hospital. Verve’s backers include GV, ARCH Venture Partners, F-Prime Capital and Bio…

VC-backed Verve Therapeutics expands scientific advisory board with new addition

Cambridge, Massachusetts-based Verve Therapeutics, a next-generation cardiovascular company, has named Dr. Andrew Geall to its scientific advisory board. Geall is vice president of formulations, analytics and chemistry at Avidity Biosciences. Verve's backers include GV, ARCH Venture Partners, F-Prim…

Verve Therapeutics Frequently Asked Questions

  • When was Verve Therapeutics founded?

    Verve Therapeutics was founded in 2018.

  • Who are Verve Therapeutics key executives?

    Verve Therapeutics's key executives are Kiran Musunuru, David Neafus and Keith Joung.

  • How many employees does Verve Therapeutics have?

    Verve Therapeutics has 29 employees.

  • Who are Verve Therapeutics competitors?

    Competitors of Verve Therapeutics include AID Genomics, Stealth BioTherapeutics and Genetron Health.

  • Where is Verve Therapeutics headquarters?

    Verve Therapeutics headquarters is located at 215 First St #440, Cambridge.

  • Where are Verve Therapeutics offices?

    Verve Therapeutics has an office in Cambridge.

  • How many offices does Verve Therapeutics have?

    Verve Therapeutics has 1 office.